Block
Block, licence 80074657: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Plexus Canada Limited Partnership dba Plexus Worldwide
- NPN or DIN-HM
- 80074657
- Status
- Active licence
- Licence date
- 28 December 2016
- Revision date
- 2 October 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ascophyllum nodosum/Fucus vesiculosus blend Source : Ascophyllum nodosum Extraction ratio : 20:1 Dry plant equivalent : 5 Grammes Potency : 0.0 > 25 mg Polyphenols | 250.0 milligramme | Not calculated |
| Ascophyllum nodosum/Fucus vesiculosus blend Source : Fucus vesiculosus - Thalle Extraction ratio : 20:1 Dry plant equivalent : 5 Grammes Potency : 0.0 > 25 mg Polyphenols | 250.0 milligramme | Not calculated |
| Chrome Source : Picolinate de chrome (III) | 100.0 microgrammes | Not calculated |
| Phaseolus vulgaris Source : Graine(s) Extraction ratio : 10:1 Dry plant equivalent : 1 Grammes Potency : 900.0 AAIU | 100.0 milligramme | Not calculated |
Non-medicinal ingredients
Microcrystalline cellulose, Hypromellose, Dioxyde de silicium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Provides support for healthy glucose metabolism. Helps to maintain the body's ability to metabolize nutrients. Helps to prevent chromium deficiency. Helps support healthy blood glucose levels. Helps reduce the glycemic index of ingested foods. Helps in the function of the thyroid gland. Helps to maintain normal production of thyroid hormones. Helps to prevent iodine deficiency.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80074657
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.